General Information
The Rapid COVID-19 Antigen Test is an in vitro immunochromatographic assay for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nasopharyngeal (NP) swab from individuals who are suspected of COVID-19 by their healthcare provider. It is intended to aid in the rapid diagnosis of SARS-CoV-2 infections.
Warnings
This test has not been reviewed by the FDA. Negative results do not rule out SARS-CoV-2 infection, particularly those who have been in contact with the virus. Follow up testing with a molecular diagnostic test should be considered to rule out infection in these individuals.
Common Uses
Qualitative, visually read results in 15 minutes. No instrument required. Room temperature storage or refrigerated (2-30°C / 36-86°F). Procedural internal control included. Sterile Swabs, Extraction Buffer and Extraction Tubes included.
